![]() |
市场调查报告书
商品编码
1744611
2032 年细胞农业市场预测:按产品类型、来源、分销管道、技术、应用和地区进行的全球分析Cellular Agriculture Market Forecasts to 2032 - Global Analysis By Product Type (Tofu, Tempeh, Seitan, Quorn, and Other Product Types), Type, Source, Distribution Channel, Technology, Application and By Geography |
根据 Stratistics MRC 的数据,全球细胞农业市场预计在 2025 年达到 2,461.4 亿美元,到 2032 年将达到 7,887.5 亿美元,预测期内的复合年增长率为 18.1%。
细胞农业是生物技术的一个分支,专注于直接从细胞中生产农产品,而不是饲养动物或培育植物。它涉及培养动物细胞或利用微生物来生产肉类、乳製品、蛋类、皮革和其他材料。细胞农业旨在绕过传统农业,减少对环境的影响,提高粮食安全,并提供符合伦理道德的替代方案,同时保持与传统畜牧业相似的口感、质地和营养价值。
根据粮农组织统计资料库 (FAOSTAT) 的数据,小麦产量预计将从 2022 年的每公顷 3,704.4 公斤下降到 2023 年的每公顷 3,625 公斤,大麦和其他粗粒产量也将出现类似的下降趋势。
对永续蛋白质的需求不断增加
细胞农业市场对永续蛋白质的需求日益增长,这源自于对更有效率、更环保的食品生产系统的需求。人口成长和肉类消费的增加进一步加剧了资源紧张,从而加速了人们对实验室培育替代品的兴趣。注重健康的消费者更青睐更干净、不含抗生素的蛋白质,而对动物福利的伦理担忧则推动了对零残忍产品的需求。此外,大型食品公司的扶持政策和投资进一步提振了市场,将细胞蛋白定位为未来食品安全的永续解决方案。
来自植物来源品的竞争压力
与实验室培育肉类不同,植物来源替代品无需监管审查,开发週期更短,并受益于现有供应链,因此更容易获得。此外,消费者对植物来源替代品的熟悉度和偏好,使其被认为更天然,这为细胞蛋白质的市场占有率扩张带来了障碍。由于细胞农业仍面临高昂的生产成本,价格敏感度进一步青睐植物来源产品。这种竞争格局迫使细胞蛋白公司快速创新,同时克服成本和可扩展性障碍。
不断增长的粮食安全需求
由于传统畜牧业面临环境限制和资源效率低下的困境,日益增长的粮食安全需求正推动细胞农业市场的成长。细胞农业提供了一种永续的替代方案,它只需极少的土地和水资源,同时避免了传统畜牧业对生态系统的影响。此外,透过在受控环境中实现本地生产,细胞农业减少了对易受干扰的复杂供应链的依赖。这使得培养蛋白质成为一种策略解决方案,能够在日益增长的需求和气候不确定性面前,建构更具韧性和适应性的粮食体系。
漫长的开发週期
冗长的研发和监管障碍会推迟产品上市,增加成本并降低投资者信心。这些阻碍阻碍了市场扩张,使传统农业得以保持主导地位。此外,漫长的开发週期也可能导致技术过时,因为新技术的进步可能超过现有技术。漫长的等待时间也会降低消费者信心和采用率,因为这会引发人们对扩充性和可负担性的怀疑。
COVID-19的影响
新冠疫情暴露了传统肉类供应链的脆弱性,包括屠宰场关闭和通用感染疾病的风险,这加速了人们对细胞农业的兴趣。由于封锁措施中断了传统生产,对实验室培育蛋白质等韧性替代方案的需求增加。随着相关人员寻求能够抵御疫情的肉类解决方案,以及消费者对永续食品选择的认识不断提高,投资激增。然而,研发延迟和资金筹措挑战暂时减缓了进展。整体而言,这场危机凸显了对去中心化、安全食品体系的需求,并将细胞农业定位为应对未来中断的长期解决方案。
分离物部分预计将在预测期内占据最大份额
预计分离物细分市场将在预测期内占据最大市场占有率。这归因于高效生产实验室人造肉类对纯净且可扩展的细胞株的需求。关键成长要素包括干细胞技术的进步、为降低成本而大力推广无血清培养基,以及对稳定、无污染投入的需求。食品安全监管要求也强调了特性明确的分离物在确保产品品质和商业性可行性方面的重要性。
预计预测期内组织工程领域将以最高的复合年增长率成长。
预计组织工程领域将在预测期内实现最高成长率,这得益于对结构化、逼真的肉类替代品(可模拟传统肉类)的需求。关键驱动因素包括3D生物列印、支架开发和细胞培养技术的进步,这些技术使肌肉和脂肪组织的可扩展生产成为可能。消费者对真实质地和口味的期望,以及永续性和伦理方面的考量,将进一步推动组织工程食品的创新。
预计亚太地区将在预测期内占据最大的市场占有率,这得益于肉类需求的不断增长和耕地面积的有限,这推动了永续替代品的出现。新加坡、日本和中国的政府支持、研发投入以及新创企业的新兴企业正在加速。日益增强的健康和环保意识,加上对食品安全的担忧,正在推动肉类的普及。此外,监管部门的核准以及与传统肉类生产商的合作,也进一步推动了该地区市场的扩张。
预计北美将在预测期内实现最高的复合年增长率。这得益于消费者对永续和符合道德标准的蛋白质的强劲需求,以及气候意识的增强。科技公司和食品巨头的大量投资、美国食品药物管理局 (FDA)/美国农业部的监管支持以及蓬勃发展的新兴企业生态系统正在刺激创新。此外,积极的政府措施和与研究机构的合作正在加速美国和加拿大的产品开发和商业化。
According to Stratistics MRC, the Global Cellular Agriculture Market is accounted for $246.14 billion in 2025 and is expected to reach $788.75 billion by 2032 growing at a CAGR of 18.1% during the forecast period. Cellular agriculture is a field of biotechnology that focuses on producing agricultural products directly from cells, rather than raising animals or growing plants. It involves cultivating animal cells or using microorganisms to create meat, dairy, eggs, leather, and other materials. By bypassing traditional farming, cellular agriculture aims to reduce environmental impact, improve food security, and offer ethical alternatives to conventional animal agriculture while maintaining similar taste, texture, and nutritional value.
According to FAOSTAT data, wheat yields decreased from 3,704.4 kg/ha in 2022 to 3,625 kg/ha in 2023, with similar declining trends observed in barley and other coarse grains.
Rising demand for sustainable protein
The rising demand for sustainable protein in the cellular agriculture market is fuelled by the need for more efficient and eco-friendly food production systems, as conventional animal farming struggles to meet global protein demands without excessive environmental harm. Increasing population growth and meat consumption further strain resources, accelerating interest in lab-grown alternatives. Health-conscious consumers prefer cleaner, antibiotic-free protein, while ethical concerns over animal welfare drive demand for cruelty-free options. Additionally, supportive policies and investments from major food companies further propel the market, positioning cell-based protein as a sustainable solution for future food security.
Competitive pressure from plant-based alternatives
Unlike lab-grown meat, plant-based alternatives require less regulatory scrutiny, have shorter development cycles, and benefit from existing supply chains, making them more accessible. Additionally, consumer familiarity and preference for plant-based options, perceived as more natural, create hurdles for cell-based proteins to gain market share. Price sensitivity further favours plant-based products, as cellular agriculture still faces high production costs. This competitive landscape forces cell-based protein companies to innovate rapidly while overcoming cost and scalability barriers.
Increasing food security needs
As conventional animal farming struggles with environmental constraints and resource inefficiencies, the increasing need for food security is accelerating growth in the cellular agriculture market. Cellular agriculture provides a sustainable alternative, requiring minimal land and water while avoiding the ecological impacts of traditional livestock production. Moreover, by enabling local production in controlled environments, cellular agriculture reduces dependence on complex supply chains vulnerable to disruptions. This positions cultured proteins as a strategic solution for building more resilient and adaptable food systems in the face of growing demand and climate uncertainties.
Long development timelines
Extended research and regulatory hurdles slow product launches, increasing costs and reducing investor confidence. This stagnation can hinder market expansion, allowing traditional agriculture to maintain dominance. Moreover, prolonged timelines risk technological obsolescence, as newer advancements may outpace current developments. Consumer trust and adoption rates also suffer, as long waits can lead to skepticism about scalability and affordability.
Covid-19 Impact
The COVID-19 pandemic accelerated interest in cellular agriculture by exposing vulnerabilities in traditional meat supply chains, including slaughterhouse closures and zoonotic disease risks. Lockdowns disrupted conventional production, boosting demand for resilient alternatives like lab-grown protein. Investment surged as stakeholders sought pandemic-proof food solutions, while consumer awareness of sustainable options grew. However, R&D delays and funding challenges temporarily slowed progress. Overall, the crisis highlighted the need for decentralized, secure food systems, positioning cellular agriculture as a long-term solution for future disruptions.
The isolates segment is expected to be the largest during the forecast period
The isolates segment is expected to account for the largest market share during the forecast period, driven by the need for pure, scalable cell lines to produce lab-grown meat efficiently. Key growth factors include advancements in stem cell technology, the push for serum-free media to reduce costs, and the demand for consistent, contamination-free inputs. Regulatory requirements for food safety also emphasize the importance of well-characterized isolates in ensuring product quality and commercial viability.
The tissue engineering segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the tissue engineering segment is predicted to witness the highest growth rate, due to the demand for structured, realistic meat alternatives that mimic conventional meat. Key factors include advancements in 3D bio-printing, scaffold development, and cell culture techniques, enabling scalable production of muscle and fat tissues. Consumer expectations for authentic texture and taste, alongside sustainability and ethical concerns, further accelerate innovation in tissue-engineered food products.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising meat demand, and limited agricultural land, pushing sustainable alternatives. Government support, R&D investments, and start-ups in Singapore, Japan, and China accelerate innovation. Growing health and environmental awareness, coupled with food security concerns, boost adoption. In addition, regulatory approvals and partnerships with traditional meat producers further propel market expansion in the region.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by strong consumer demand for sustainable, ethical protein, backed by rising climate consciousness. Heavy investments from tech and food giants, supportive FDA/USDA regulations, and a thriving start-ups ecosystem drive innovation. Additionally, proactive government initiatives and partnerships with research institutions are accelerating product development and commercialization across the U.S. and Canada.
Key players in the market
Some of the key players profiled in the Cellular Agriculture Market include Eat Just, Inc., Perfect Day, Inc., Aleph Farms, UPSIDE Foods, BlueNalu, Inc., Formo GmbH, Remilk, Mosa Meat, Finless Foods, Meatable, Air Protein, Avant Meats, SuperMeat, Wildtype, and Shiok Meats.
In May 2025, Eat Just, Inc., has launched its new protein powder, Just One, which is now available at Whole Foods Market locations across the United States. This product is distinct for being made with just one ingredient: mung beans, a legume known for its high protein content and sustainability.
In January 2025, Upside Foods is aiming to launch chicken shreds its second product in the US by year-end. Despite its legal battle against Florida's leaders and an uncertain political landscape around alternative proteins, Upside Foods is looking to move forward. While the Californian startup is cleared to sell its cultivated chicken fillet containing 99% chicken cells it stopped selling this at restaurants last year with the product is in relatively tight supply.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.